Director/PDMR Shareholding and Total Voting Rights

RNS Number : 0636I

Craneware plc

19 March 2018

 

Craneware plc

("Craneware", the "Group" or the "Company")

Director/PDMR Shareholding

and

Total Voting Rights

Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 16 March 2018, Craig Preston, CFO of the Company, exercised options over a total of 194,229 ordinary shares of 1p each in the Company ("Ordinary Shares"). In order to fulfil obligations related to the exercise, Mr Preston subsequently sold 112,126 Ordinary Shares at a price of 1,950 pence per share.  

Following these transactions, Mr Preston's shareholding has increased to a total of 82,103 Ordinary Shares, representing 0.3 per cent. of the Company's issued share capital.

Also on 16 March 2018, certain employees of the Company exercised options over Ordinary Shares. The exercise of these options, as well as the exercise of Mr Preston's options, were satisfied by the Company's existing block listing. 

Following the exercise of these options described above, the Company's issued share capital consists of 26,662,271 Ordinary Shares. Accordingly, the figure of 26,662,271 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name:	Craig Preston
2	Reason for the notification
a)	Position/Status:	Chief Financial Officer
b)	Initial Notification/Amendment:	Initial Notification
3	Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor
a)	Name:	Craneware plc
b)	LEI:	213800O2CTJ1YFXNXG05
4.	Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
a)	Description of the financial instrument: Identification code:	Ordinary Shares ISIN GB00B2425G68
b)	Nature of the transaction:	Exercise of options over Ordinary Shares
c)	Price(s) and volume(s):	Price(s)	Volume(s)
		£2.08 £3.35 £4.01 £4.00 £3.95 £5.22	72,115 25,099 11,721 16,027 32,459 36,808
d)	Aggregated price(s) and volume(s):	Price(s)	Volume(s)
		£3.428	194,229
e)	Date of the Transaction:	16 March 2018
f)	Place of the Transaction:	Outside of a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name:	Craig Preston
2	Reason for the notification
a)	Position/Status:	Chief Financial Officer
b)	Initial Notification/Amendment:	Initial Notification
3	Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor
a)	Name:	Craneware plc
b)	LEI:	213800O2CTJ1YFXNXG05
4.	Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
a)	Description of the financial instrument: Identification code:	Ordinary Shares ISIN GB00B2425G68
b)	Nature of the transaction:	Sale of Ordinary Shares
c)	Price(s) and volume(s):	Price(s)	Volume(s)
		£19.50	112,126
d)	Aggregated price(s) and volume(s):	Price(s)	Volume(s)
		£19.50	112,126
e)	Date of the Transaction:	16 March 2018
f)	Place of the Transaction:	London Stock Exchange

For further information, please contact:

Craneware plc	Peel Hunt	Alma
[phone]	[phone]	[phone]
Keith Neilson, CEO	Dan Webster	Caroline Forde
Craig Preston, CFO	George Sellar	Robyn Fisher
	Nicole McDougall

About Craneware

Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The Company's flagship solution, Chargemaster Toolkit®, has earned the KLAS No.1 ranking in Revenue Cycle - Chargemaster Management since 2006 and is part of Craneware's value cycle management suite, which includes patient engagement, charge capture and pricing, claims analysis, revenue recovery and retention, and cost analytics solutions.

Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff.

Learn more at www.craneware.com.

 

END

 

 

DSHSFDFMAFASEID